Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury.

Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury.

Item
http://www.wikidata.org/entity/Q31617397
Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation.Molecular mechanisms of renal allograft fibrosis.Prevalence of renal dysfunction in tacrolimus-treated pediatric transplant recipients: a systematic review.Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome.Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.Microemulsion cyclosporin inhibits vascular remodelling and attenuates associated changes in profibrotic gene expression in an experimental model of allograft vasculopathy.The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion.
P2860

Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury.

Item
http://www.wikidata.org/entity/Q31617397
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tacrolimus has less fibrogenic ...... ischaemia-reperfusion injury.
@ast
Tacrolimus has less fibrogenic ...... ischaemia-reperfusion injury.
@en
type
label
Tacrolimus has less fibrogenic ...... ischaemia-reperfusion injury.
@ast
Tacrolimus has less fibrogenic ...... ischaemia-reperfusion injury.
@en
prefLabel
Tacrolimus has less fibrogenic ...... ischaemia-reperfusion injury.
@ast
Tacrolimus has less fibrogenic ...... ischaemia-reperfusion injury.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Tacrolimus has less fibrogenic ...... ischaemia-reperfusion injury.
@en
P2093
P2860
P304
P31
P356
10.1046/J.1365-2168.2000.01576.X
P407
P433
P478
P577
P698
P921